MedTrace Logo

Ovarian Hyperstimulation Syndrome Prevention

NCT06739759 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-12-18

No results posted yet for this study

Summary

Ovarian hyperstimulation is a very hazardous complication of ICSI

Conditions

  • Ovarian Hyper Stimulation Syndrome (OHSS)

Interventions

DRUG

Antagonist protocol for IVF

antagonist protocol with triggering by Decapeptyl

DRUG

Modified Agonist protocol for IVF with additive treatments as HCQ

giving additive drugs to agonist protocolas HCQ

Sponsors & Collaborators

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy, MD · Aljazeera Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-17
Primary Completion
2025-06-30
Completion
2025-07-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06739759 on ClinicalTrials.gov